<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/40E23D5D-D55B-4F07-AF6C-1EA32F5E8C43"><gtr:id>40E23D5D-D55B-4F07-AF6C-1EA32F5E8C43</gtr:id><gtr:firstName>Ken</gtr:firstName><gtr:surname>Suzuki</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F158"><gtr:id>1C52A434-2213-4399-A11C-B538E7EC9DD6</gtr:id><gtr:title>Role of Cell Transplantation in Treating Heart Failure</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/158</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Cell transplantation is a promising strategy for treating heart failure. Research has demonstrated that some types of cells, such as skeletal myoblasts, survive and differentiate after grafting into the myocardium, and this is associated with improved cardiac function in experimental heart failure models. This has prompted the transplantation of these cells into the myocardium of humans in an attempt to establish safety and efficiency. We strongly believe that the future success of the therapy critically depends on resolving several fundamental issues by laboratory research. These include unclear mechanisms of the therapeutic effects achieved by this strategy and inadequate graft quality. The proposed research aims to investigate various aspects of graft behaviour in a cardiac environment, such as death/survival, proliferation, differentiation, integration and interaction between two kinds of muscle cells at genetic, molecular and cellular levels. The specific aims are: [1] study of cell-migration from the intra-vascular to the myocardial interstitial space following intra-coronary infusion; [2] investigation of detailed graft survival, proliferation and the causes of death; [3] attempt to improve graft survival with physical (heat shock), pharmacological (SOD, anti-cytokine antibody) and genetic (Bcl-2) procedures; [4] study of gap junction formation between skeletal myoblasts and cardiomyocytes in vitro co-culture system and in vivo cell transplantation; [5] evaluation of the effect of connexin 43 overexpression on gap junction formation between the two types of cells; [6] investigation of differentiation and possible phenotype modulation (skeletal to cardiac) of the skeletal graft; [7] study of interacting influence of the graft on the native myocardium; [8] investigation of the effect of overexpression of IL-1 receptor antagonist on attenuating remodelling in failing hearts and enhancing cell transplantation effects.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1135980</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Prof Nadia Rosenthal</gtr:description><gtr:id>6205A560-4533-4BD8-8A5A-84EDDEF5C184</gtr:id><gtr:impact>MRC Collaboration grant, resulted in publications in top journals (Circulation, Circulation Research).</gtr:impact><gtr:outcomeId>ne2zhbZnjTA-1</gtr:outcomeId><gtr:partnerContribution>Exchange of research expertise</gtr:partnerContribution><gtr:piContribution>Exchange of research expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>WHRI open seminar 2007</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>74E82AAB-5220-4E1A-82F2-57BC16C1C5A0</gtr:id><gtr:impact>William Haarvey Research Intitute Cardiovascular Stem Cell Conference attended by 200 audiences including basic scientists, clinicians and lay people. 1 day conference.

wide dissemination of the research among scientists, clinicians, and lay people.</gtr:impact><gtr:outcomeId>C4C75301BA9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHRI open seminar 2008</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B12902BA-984B-4321-892D-3A5AD9EE6F8D</gtr:id><gtr:impact>The second William harvey Research Intitute Cardiobvascular Stem Cell Conference attended by 100 clinicans and basic scientists. A half day course. 45 min talk was given.

wide dissemination of the resaerch among scientists, clinicians and lay people.</gtr:impact><gtr:outcomeId>E108BF2ADD8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sasakawa Foundation Grant</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>The Nippon Foundation</gtr:fundingOrg><gtr:id>FECEC69F-5F77-416F-BDA8-7FAF2DD554A5</gtr:id><gtr:outcomeId>39ACB63B1CF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>322006</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC (Yashiro NIRG)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900105</gtr:fundingRef><gtr:id>0CB449EF-C19E-49FD-B4E2-27A034E56154</gtr:id><gtr:outcomeId>YHSVVFyvXNU</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Collaboration Grant</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>51336899-B9E2-406E-8741-C10F8F5331E0</gtr:id><gtr:outcomeId>097E07BCDB60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>111950</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HRUK (allo M-sheet)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:fundingRef>TRP04/12</gtr:fundingRef><gtr:id>817A75B7-DBA2-40F7-BBCC-8E33C7020E91</gtr:id><gtr:outcomeId>RFadzfVFvy9</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CellSeed</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>CellSeed, Inc.</gtr:fundingOrg><gtr:id>DD35225F-21E0-4864-AA07-F7680FE9CCA6</gtr:id><gtr:outcomeId>SzdNGFqbTCk</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140486</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant (M-sheet)</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/12/10/29389</gtr:fundingRef><gtr:id>B2967C01-CEB4-4C77-B484-69FEE6C09FF2</gtr:id><gtr:outcomeId>DvgbX1zNzNc</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Barts Charity (start-up)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:id>CC5F3EF0-ADCA-4EFA-B89F-A87F6653A9B2</gtr:id><gtr:outcomeId>BC9999DE8F00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HRUK (retro)</gtr:description><gtr:end>2007-06-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:id>E16986D4-602D-4034-8212-4C2949374BEF</gtr:id><gtr:outcomeId>AD4D37409580</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1CD6EB8A-2D32-4CCB-B7C3-D97603DBE2EE</gtr:id><gtr:title>Prevention of adriamycin induced heart failure by an increase in endogenous adenosine production.</gtr:title><gtr:parentPublicationTitle>Nucleosides, nucleotides &amp; nucleic acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a27cb8853a45519569c2981e68d5dec"><gtr:id>7a27cb8853a45519569c2981e68d5dec</gtr:id><gtr:otherNames>Yuen AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1525-7770</gtr:issn><gtr:outcomeId>CB89177FFD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B42FD6E6-F6B8-450A-8013-5254C18FEA7E</gtr:id><gtr:title>Evaluation of frequency, type, and function of gap junctions between skeletal myoblasts overexpressing connexin43 and cardiomyocytes: relevance to cell transplantation.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b700c8271973dfdba913d7cf78c9ed"><gtr:id>97b700c8271973dfdba913d7cf78c9ed</gtr:id><gtr:otherNames>Stagg MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>383E64956FC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D92FB3FA-ACCB-4F48-A028-902040DCD84C</gtr:id><gtr:title>Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94ef51efba953dd8ac8f84b9ab5cfc10"><gtr:id>94ef51efba953dd8ac8f84b9ab5cfc10</gtr:id><gtr:otherNames>Suzuki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>4F87FD345EA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF6E2CDB-378E-4707-A490-738A42C44A6E</gtr:id><gtr:title>Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eec8e6f3accbcebf7eb18f636c9facf"><gtr:id>0eec8e6f3accbcebf7eb18f636c9facf</gtr:id><gtr:otherNames>Smolenski RT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>47D2B69B24A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>751A122E-6CB1-4955-A6CE-7C98A54B0489</gtr:id><gtr:title>Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd0a3e1c9bc8308f5df54fd0b1419fb"><gtr:id>bcd0a3e1c9bc8308f5df54fd0b1419fb</gtr:id><gtr:otherNames>Fukushima S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>10DE80B379C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D47C111-72FF-4832-AF45-D267FE7DCED6</gtr:id><gtr:title>Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c31e0ccdfd753f597df8f56bd125a306"><gtr:id>c31e0ccdfd753f597df8f56bd125a306</gtr:id><gtr:otherNames>Takahashi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>1E34A6CB7BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC69853D-0103-46BB-BEC2-E003F0B5759B</gtr:id><gtr:title>A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd0a3e1c9bc8308f5df54fd0b1419fb"><gtr:id>bcd0a3e1c9bc8308f5df54fd0b1419fb</gtr:id><gtr:otherNames>Fukushima S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>ABB1A6BAE7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE2F201C-5748-4916-B172-B316FD89E892</gtr:id><gtr:title>Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbe5553244420fe7a6465a5064ef6188"><gtr:id>cbe5553244420fe7a6465a5064ef6188</gtr:id><gtr:otherNames>Murtuza B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D3C47DB0824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A34D4B5-85B3-4CD2-9213-B46129FBDC6C</gtr:id><gtr:title>Extracellular high mobility group box 1 plays a role in the effect of bone marrow mononuclear cell transplantation for heart failure.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4150b273adb55ca7fee762053c343ddc"><gtr:id>4150b273adb55ca7fee762053c343ddc</gtr:id><gtr:otherNames>Kaneko M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e17be17bf015f0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>654DF530-E609-4249-834B-78E263AB08AE</gtr:id><gtr:title>The future of regenerative therapy in patients with chronic heart failure.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Cardiovascular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f753e0df1405b6af326b572e7621e8"><gtr:id>64f753e0df1405b6af326b572e7621e8</gtr:id><gtr:otherNames>Yacoub M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1743-4297</gtr:issn><gtr:outcomeId>0086E700AD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22F2E5E2-C27C-4F1F-AE3B-483DC406317E</gtr:id><gtr:title>Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries.</gtr:title><gtr:parentPublicationTitle>The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd0a3e1c9bc8308f5df54fd0b1419fb"><gtr:id>bcd0a3e1c9bc8308f5df54fd0b1419fb</gtr:id><gtr:otherNames>Fukushima S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-2498</gtr:issn><gtr:outcomeId>pm_13254_24_20971657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF5068E6-AE4F-4C26-9870-9976727C9C8B</gtr:id><gtr:title>Protective role of peroxisome proliferator-activated receptor-?/d in septic shock.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f1999acfee26e30ace640022e21806d"><gtr:id>4f1999acfee26e30ace640022e21806d</gtr:id><gtr:otherNames>Kapoor A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13254_24_20693380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BC5D165-626C-46D1-BED0-C77CA192F9B9</gtr:id><gtr:title>Cell delivery routes for stem cell therapy to the heart: current and future approaches.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fade30134abc26751f4ec948d7b844d0"><gtr:id>fade30134abc26751f4ec948d7b844d0</gtr:id><gtr:otherNames>Campbell NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn><gtr:outcomeId>pm_13254_24_22648235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21D2A88E-3237-4669-B14C-D25F3D87FB41</gtr:id><gtr:title>Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc385318cc9406f2fb4b1c3b23a7852f"><gtr:id>bc385318cc9406f2fb4b1c3b23a7852f</gtr:id><gtr:otherNames>Lovell MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>pm_13254_24_20810112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D20C61D7-BA25-4028-A65B-AF64AA092695</gtr:id><gtr:title>Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd0a3e1c9bc8308f5df54fd0b1419fb"><gtr:id>bcd0a3e1c9bc8308f5df54fd0b1419fb</gtr:id><gtr:otherNames>Fukushima S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>8ABB0F54BC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B632C7AD-AA13-480A-A591-CC3B04F2228F</gtr:id><gtr:title>Heterogeneic nature of adult cardiac side population cells.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82518c8aacdb63462834dfdaa56185b9"><gtr:id>82518c8aacdb63462834dfdaa56185b9</gtr:id><gtr:otherNames>Yamahara K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>99B9A710B85</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FA7F3F3-273D-4B91-A1C9-79B4A991D774</gtr:id><gtr:title>A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2afcb1bcd1c915ee118fd6ad0fb3f637"><gtr:id>2afcb1bcd1c915ee118fd6ad0fb3f637</gtr:id><gtr:otherNames>Coppen SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>37BB042D0FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23823118-3BD9-468A-BE0B-4AF57467D962</gtr:id><gtr:title>Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81d76b744822423451feedb714519aa7"><gtr:id>81d76b744822423451feedb714519aa7</gtr:id><gtr:otherNames>Shintani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>7804DD9DA53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31360849-0869-427C-A47C-06B3EDA134FB</gtr:id><gtr:title>C34T AMP deaminase 1 gene mutation protects cardiac function in donors.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9285aa263955f95a0b506a07cd11c4e"><gtr:id>d9285aa263955f95a0b506a07cd11c4e</gtr:id><gtr:otherNames>Yacoub MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>B8E9E382B9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C212EB8B-E904-463F-A46D-E4E6A35BA220</gtr:id><gtr:title>Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94ef51efba953dd8ac8f84b9ab5cfc10"><gtr:id>94ef51efba953dd8ac8f84b9ab5cfc10</gtr:id><gtr:otherNames>Suzuki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>C6660A3DBF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78438075-4A38-4442-9372-C4CD71900922</gtr:id><gtr:title>Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f3b0d1be17ddd4dddfaf7d483017db4"><gtr:id>6f3b0d1be17ddd4dddfaf7d483017db4</gtr:id><gtr:otherNames>Lee J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn><gtr:outcomeId>2D58E2D4CC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B364914A-3FE3-4C35-9BE6-88CDA0DA44F5</gtr:id><gtr:title>Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd0a3e1c9bc8308f5df54fd0b1419fb"><gtr:id>bcd0a3e1c9bc8308f5df54fd0b1419fb</gtr:id><gtr:otherNames>Fukushima S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>72B42852C11</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/158</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>